FlowMetric
Specialist contract research organisation FlowMetric has appointed Floyd Fox as Chief Scientific Officer.
Fox is an immunologist with 25 years’ experience in clinical and preclinical pharmacology, immunogenicity, cytokine biology, oncology, infection, and inflammation.
His past work has involved developing and implementing non-clinical and clinical bioanalytical methods for understanding biotherapeutics’ mechanisms of action.
Before joining FlowMetric, Fox worked for 15 years at Eli Lilly rising to Associate Vice-President, Clinical Pharmacology and Drug Disposition. He was heavily involved in commercialising Lilly’s Erbitux and Cyramza.
FlowMetric is a CRO specialising in polychromatic flow cytometry and cell sorting services for pharma companies.